We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Portola Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 162 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 162 → 0 (-162)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $1.34B → $0 (-$1.34B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 162

Holders
–
Holders Change
-162
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
162
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$126M
2
BlackRock
BlackRock
New York
-$115M
3
MF
Magnetar Financial
Illinois
-$72.3M
4
Goldman Sachs
Goldman Sachs
New York
-$64.6M
5
State Street
State Street
Massachusetts
-$63.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
101
Havens Advisors
New York
– -$657K -36,500 Closed
Rafferty Asset Management
102
Rafferty Asset Management
New York
– -$640K -35,586 Closed
Dimensional Fund Advisors
103
Dimensional Fund Advisors
Texas
– -$551K -30,637 Closed
Ohio Public Employees Retirement System (OPERS)
104
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$540K -30,000 Closed
CCM
105
Crabel Capital Management
California
– -$501K -27,871 Closed
ProShare Advisors
106
ProShare Advisors
Maryland
– -$439K -24,385 Closed
MLICM
107
Metropolitan Life Insurance Company (MetLife)
New York
– -$426K -23,656 Closed
Russell Investments Group
108
Russell Investments Group
United Kingdom
– -$417K -23,241 Closed
TAM
109
Tocqueville Asset Management
New York
– -$385K -21,415 Closed
ECM
110
ExodusPoint Capital Management
New York
– -$353K -19,645 Closed
SCA
111
Spearhead Capital Advisors
Florida
– -$330K -18,359 Closed
Walleye Trading
112
Walleye Trading
New York
– -$324K -18,001 Closed
Handelsbanken Fonder
113
Handelsbanken Fonder
Sweden
– -$324K -17,988 Closed
PA
114
Profund Advisors
Maryland
– -$311K -17,304 Closed
ASRS
115
Arizona State Retirement System
Arizona
– -$300K -16,686 Closed
PP
116
Patten & Patten
Tennessee
– -$292K -16,225 Closed
Public Employees Retirement Association of Colorado
117
Public Employees Retirement Association of Colorado
Colorado
– -$287K -15,945 Closed
BCM
118
Beryl Capital Management
California
– -$280K -15,560 Closed
UBS Group
119
UBS Group
Switzerland
– -$236K -13,084 Closed
Principal Financial Group
120
Principal Financial Group
Iowa
– -$233K -12,969 Closed
TRCT
121
Tower Research Capital (TRC)
New York
– -$228K -12,675 Closed
WA
122
Winfield Associates
Ohio
– -$228K -12,650 Closed
AB
123
Amalgamated Bank
New York
– -$226K -12,561 Closed
Two Sigma Investments
124
Two Sigma Investments
New York
– -$221K -12,300 Closed
Victory Capital Management
125
Victory Capital Management
Texas
– -$221K -12,272 Closed
3 4
5
6 7

PTLA Hedge Fund Activity: Q3 2020 in Review

0 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2020, worth a combined $0 — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 162 funds closed out of PTLA and 0 opened new positions — a net loss of 162 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $126M sold.

  • 0 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2020, down from 162 in Q2 2020.
  • Funds reported $0 of Portola Pharmaceuticals, Inc. stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2020 and 162 closed out, a net change of -162 holders.
  • The largest Portola Pharmaceuticals, Inc. seller in Q3 2020 was Vanguard Group, an estimated $126M sold.

Based on aggregated 13F filings for Q3 2020.